MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


RNS News Service

I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.

Directorate Changes

RNS

RNS Number : 8456C
Devro PLC
22 October 2020
 

22 October 2020

 

DEVRO PLC ("DEVRO" OR THE "COMPANY")

 

Directorate Changes

 

Devro, one of the world's leading manufacturers of collagen products for the food industry, announces the appointment of Chantal Cayuela to the Board as an independent non-executive director of the Company with effect from 1 January 2021.  Chantal will also become a member of the Audit Committee, the Executive Remuneration Committee and the Nomination Committee from that date.

Chantal currently leads the R&D and Innovation team for Kellogg's European business, where she has been a Vice President since 2018. In a broad-ranging, international, career working with global food manufacturers, she has helped to shape their commercial strategies through product innovation.  Her career includes a period of over sixteen years working in a variety of roles at Danone through which she developed considerable expertise in the successful delivery of customer-focused innovation.  She subsequently spent seven years leading the Group Bel's research, innovation and development during which time her leadership of, and approach to, product innovation played a pivotal role in reinvigorating the brand, enabling the business to grow beyond its traditional core cheese markets. Chantal is a French national and she holds a doctorate in Biotechnology Chemical Engineering Sciences.

Devro also announces that Dr Paul Withers, non-executive director, will retire from the Board on 31 December 2020.  Consequently, from 1 January 2021, Lesley Jackson will become the Company's Senior Independent Director.

Steve Good, Devro's Chairman, said:

"I am delighted to welcome Chantal to Devro's Board of Directors. She brings extensive experience of successful product innovation in international food manufacturing businesses and will add valuable skills and insights to support the development and execution of the Company's growth strategy. 

"On behalf of the Board, I would also like to thank Paul for his invaluable service as a non-executive director since 2011 and, particularly in the last year as the Company's Senior Independent Director, for his flexibility and contribution to the initiative to refresh the composition of the Board, completed with Chantal's appointment.  I wish him well for the future."

Nothing in connection with Chantal's appointment falls to be disclosed under LR 9.6.13.

 

ENDS

 

Contacts :

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain / Nick Hasell


Tel: 020 3727 1340

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPGAAUUPUGMG